Hiroshi Nagase - Concepedia

Author

Hiroshi Nagase

Also Known As

C. Hara, H Nagase, H. NAGASE, H. Nagase, HIROSHI NAGASE, Hiroshi NAGASE, Hiroshi Nagase, Hiroya NAGASE, Huang, Xi-Ping, Nagase Hiroshi

540

Publications

11.2K

Citations

H-Index

190

Concepts

All Affiliations

Toray Industries, Inc. (Japan)Hoshi University Kitasato University Tsukuba International University University of Tsukuba

About

Hiroshi Nagase is an author at Toray Industries, Inc. (Japan) specializing in pharmacology, medicine, and neuropharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	41	143	6K
2	Health Sciences	30	48	2.3K
3	Engineering	18	33	1.1K
4	Natural Sciences	16	27	735
5	Public Health	1	1	13

Hiroshi Nagase

241

Publications

10.3K

Citations

H-Index

Page 1

	Year	Citations
Dynorphin Acts as a Neuromodulator to Inhibit Itch in the Dorsal Horn of the Spinal Cord Adam Kardon, Erika Polgár, Junichi Hachisuka, Neuron	2014	352
Application of the message-address concept in the design of highly potent and selective non-peptide .delta. opioid receptor antagonists P. S. Portoghese, Marjia Sultana, Hiroshi Nagase, Journal of Medicinal Chemistry Molecular PharmacologyOpioid Receptor AntagonistsMessage-address ConceptMedicineDrug Discovery	1988	304
Thermal stress in GaN epitaxial layers grown on sapphire substrates Takahiro Kozawa, Tetsu Kachi, H. Kano, Journal of Applied Physics Materials ScienceWide-bandgap SemiconductorElectrical EngineeringThermal StressEngineering	1995	297
Nor-binaltorphimine: a potent and selective kappa-opioid receptor antagonist with long-lasting activity in vivo. T Endoh, Hideo Matsuura, Chiaki Tanaka, PubMed Pain MedicineMolecular PainPharmacotherapyLong-lasting ActivityExperimental Pharmacology	1992	211
Opioid-Induced Second Window of Cardioprotection Ryan M. Fryer, Anna K. Hsu, Janis T. Eells, Circulation Research	1999	206
Antipruritic activity of the κ-opioid receptor agonist, TRK-820 Yuko Togashi, Hideo Umeuchi, Kiyoshi Okano, European Journal of Pharmacology Molecular PharmacologyPain MedicineMedicineNeuropharmacologyExperimental Pharmacology	2002	204
A highly selective δ1-opioid receptor antagonist: 7-benzylidenenaltrexone Philip S. Portoghese, Marjia Sultana, Hiroshi Nagase, European Journal of Pharmacology Molecular PharmacologyMedicineDrug DiscoveryPharmacological AgentNeuropharmacology	1992	190
Discovery of a Structurally Novel Opioid .KAPPA.-Agonist Derived from 4,5-Epoxymorphinan. Hiroshi Nagase, Jun Hayakawa, Kuniaki Kawamura, Chemical and Pharmaceutical Bulletin Molecular PharmacologyBiochemistryMedicineMechanism Of ActionReceptor (Biochemistry)	1998	187
Potential Anxiolytic and Antidepressant-Like Activities of SNC80, a Selective δ-Opioid Agonist, in Behavioral Models in Rodents Akiyoshi Saitoh, Yuji Kimura, Tomohiko Suzuki, Journal of Pharmacological Sciences	2004	177
Blockade of morphine reward through the activation of κ-opioid receptors in mice Masahiko Funada, Tsutomu Suzuki, Minoru Narita, Neuropharmacology Molecular Pharmacologyκ-Opioid ReceptorsHealth SciencesAddictionPain Medicine	1993	167

Page 1